Non-small cell lung cancer

[1]  J. Main,et al.  Vindesine and mitomycin C in inoperable non-small cell lung cancer. , 1986, European journal of cancer & clinical oncology.

[2]  P. Rocmans,et al.  Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium). , 1986, Cancer treatment reports.

[3]  P. Quesenberry,et al.  Vindesine and mitomycin in the treatment of advanced non-small cell lung cancer: a Southeastern Cancer Study Group Trial. , 1986, Cancer treatment reports.

[4]  J. Sculier,et al.  Progress in chemotherapy of non-small cell lung cancer. , 1984, European journal of cancer & clinical oncology.

[5]  D. Budman,et al.  Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma. , 1983, Cancer treatment reports.

[6]  M. Bakowski,et al.  Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future. , 1983, Cancer treatment reviews.

[7]  J. Klastersky,et al.  Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium) , 1982, Cancer.

[8]  M. Palmer,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1982, British Journal of Cancer.

[9]  N. Martini,et al.  Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. , 1981, Annals of internal medicine.

[10]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[11]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[12]  D. Ettinger,et al.  A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.